Cromos Pharma supporting clinical research to beat heart disease
World Heart Day (Wednesday, 29 September) is a day to raise awareness about the importance of your heart and ways to keep your heart healthy – no matter what age you are. It is also a day to recognize the incredible achievements in clinical research that have helped develop innovative therapies and treatments to improve the lives of patients with heart disease. Cromos Pharma is proud to play its part in supporting clinical research to make breakthroughs in the treatment of heart disease.
Global burden of cardiovascular disease
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year[i]. CVD is an umbrella term for disorders of the heart and blood vessels. CVDs include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.
Worldwide over 500 million people are living with CVDs. Four out of five CVD deaths are due to heart attacks and strokes and one third of these deaths occur in people under 70 years of age.
Reducing your risks of heart disease
There are ways to reduce your risk of developing CVDs. Stopping smoking, reducing your intake of salt, eating more fruit and vegetables, getting regular physical activity and avoiding harmful use of alcohol have been shown to reduce the risk of cardiovascular disease.
Public health policies that support the adoption of “heart healthy” lifestyles and behaviors can also help address the global burden of CVDs. These include initiatives that make healthy eating choices more affordable, education programs from an early age on the risk factors for heart disease and support programs to help smoking cessation and reduction of alcohol consumption.
Clinical research and CVDs
Clinical research plays a vital role in addressing the global burden of CVDs by helping to identify causes and risks of heart diseases, developing innovative diagnostic tools to help detect CVDs earlier, and advancing novel therapies and treatments.
Cromos Pharma supporting CVD clinical trials
Cromos Pharma is proud to play its part in supporting clinical research to make breakthroughs in the treatment of CVDs. It has a strong track record over 16+ years of managing all aspects of cardiovascular clinical trials across all phases.
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Turkey to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.
If you have any questions or want to find out more about how Cromos Pharma can support your next clinical program please get in touch with us by emailing email@example.com.